Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
BellRing Brands (BRBR) Could See +18% Gain to Reach $16 Target

BellRing Brands (BRBR) Could See +18% Gain to Reach $16 Target

Key Takeaways

  • The $16 central target is the arithmetic mean of the analyst price targets that sit above the current share price — roughly $14, $15, $15, and $20 — not the full Street consensus.
  • The overall average of about 15 analyst targets is roughly $13.35, with a wide low-to-high range of approximately $9 to $20, underscoring deep disagreement among analysts.
  • At a latest verified price near $13.58, reaching $16 would require a gain of about 18% — a substantial move.
  • Bulls cite resilient Premier Protein consumption, record distribution gains, and a compressed valuation; bears emphasize collapsing margins and a cautious fiscal 2027 outlook.
  • The largest risk is continued gross-margin erosion from protein and freight inflation, tariffs, and elevated promotional activity.
  • For more detail, explore the stock's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers can also explore Trending AI Robots for additional automated market analysis.

Understanding the Analyst Consensus

BellRing Brands, Inc. (BRBR), the maker of Premier Protein ready-to-drink (RTD) shakes and Dymatize protein powders, has been one of the more volatile consumer staples names of the past two years. BellRing is covered by roughly 15 analysts, with a consensus rating near "Buy" or "Moderate Buy." Individual current targets cluster in a wide band: Barclays at $12, Bernstein and Deutsche Bank at $13, UBS at $9.50, and TD Cowen and Bank of America at $9, alongside J.P. Morgan and D.A. Davidson at $15 and Stifel at $14. The full range runs from about $9 to $20, and the overall average is near $13.35 — essentially at or just below the latest share price.

Because the full mean sits below the current price, a meaningful upside objective requires averaging only the targets above the current level. Those four verifiable targets — roughly $14, $15, $15, and $20 — average to $16, which is the central target used here. Notably, recent revisions have skewed lower: J.P. Morgan cut from $18 to $15, UBS from $14 to $9.50, TD Cowen from $12 to $9, and Bank of America from $10 to $9, while BNP Paribas Exane initiated coverage with an Outperform rating in October. Bulls emphasize discounted valuation and durable brand equity; cautious analysts focus on execution risk in an increasingly crowded protein category. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where the Stock Stands Today

Shares traded near $13.58, up more than 20% in a single session after fiscal fourth-quarter results, though still down roughly 62% over the past 12 months. From that level, reaching $16 requires about an 18% advance — a substantial move rather than a trivial one. The path likely hinges on margin recovery. Fiscal fourth-quarter adjusted gross margin fell to 20.1% from 29.7% a year earlier, and fiscal 2027 guidance for $310–$350 million in adjusted EBITDA implies a roughly 14% margin, well below prior peaks. Trailing valuation is compressed at a single-digit P/E, meaning even a partial normalization of profitability could re-rate the stock — but only if execution improves.

Drivers That Could Push Toward the Target

  • Resilient demand: Premier Protein shake dollar consumption rose 9% with low-teens volume growth, and the RTD shake category grew about 11–12% in fiscal 2026.
  • Brand strength: household penetration reached a record 22.4%, with a 54% repeat rate — the highest in the category — and a leading 23% dollar share.
  • Distribution expansion: total points of distribution grew 36% year over year, and fourth-quarter revenue of $692 million beat estimates by a wide margin.
  • Valuation and capital returns: a single-digit P/E and ongoing share repurchases offer a low base from which a re-rating could occur.

Risks That Could Hold It Back

  • Margin compression: adjusted gross margin fell 960 basis points year over year on protein and freight inflation, tariffs, and trade investment, and adjusted EPS of $0.22 missed estimates.
  • Weak guidance: fiscal 2027 net sales of $2.32–$2.42 billion implies roughly flat to slightly declining revenue, below the prior consensus near $2.38 billion.
  • Competitive intensity: elevated promotional activity, powder-category distribution losses, and Dymatize domestic volume declines weigh on growth.
  • Sentiment risk: a series of downgrades and target cuts — including Bank of America to Sell — could keep a ceiling on the multiple.

Technical Levels to Watch

BRBR's 52-week range extends from $7.33 to $33.56, leaving the stock in the lower portion of that span after a deep multi-year downtrend from its 2024 peak. The $7.33 low is the key support level, with $10 acting as a psychological floor. On the upside, the $15-to-$20 zone — where several analyst targets cluster — forms near-term resistance, while the 52-week high near $33.56 remains far above current levels.

Key Factors to Monitor Going Forward

Analyst price targets generally reflect a roughly 12-month research horizon, and BellRing's wide target range shows that horizon assumptions differ meaningfully between firms. Key items to watch include the next fiscal quarterly report, the trajectory of gross margin and adjusted EBITDA against the fiscal 2027 guidance, category consumption and promotional data, any further analyst target revisions, and developments in tariffs and input costs that directly affect the cost base. From what I see, monitoring these elements will be essential to gauge whether the stock can sustain momentum.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like BRBR, this kind of automated, always-on surveillance can help traders spot shifting trends, discover new opportunities, and monitor existing positions more efficiently than manual screening alone. I find it useful to review these signals regularly as conditions evolve for names facing margin and competitive pressures.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BRBR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BRBR in upward trend: price rose above 50-day moving average on October 30, 2026

BRBR moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on BRBR as a result. In 60 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

The 10-day moving average for BRBR crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +5.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in 204 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 171 of 225 cases where BRBR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

BRBR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.280) is normal, around the industry mean (6.914). P/E Ratio (6.406) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (5.003).

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. BRBR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NYSE:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.55B. The market cap for tickers in the group ranges from 68.81K to 239.66B. NSRGY holds the highest valuation in this group at 239.66B. The lowest valued company is THRC at 68.81K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -5%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -20%. BRBR experienced the highest price growth at 36%, while PRE experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 52
Price Growth Rating: 63
SMR Rating: 78
Profit Risk Rating: 92
Seasonality Score: 17 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry FoodMajorDiversified

Industry
N/A
Address
2503 South Hanley Road
Phone
+1 314 644-7600
Employees
530
Web
https://www.bellring.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.